Cravath Publishes Winter 2026 Issue of Alumni Journal
Cravath represented Credit Suisse AG in connection with the arrangement of a $650 million senior secured first lien term loan facility and a $150 million senior secured second lien term loan facility, and UBS AG in connection with the arrangement of a $120 million senior secured ABL facility. In each case, the loans were made available to an affiliate of CVC Capital Partners Advisory (U.S.), Inc. and BA Glass B.V. to finance their acquisition of the shares of Glass Container Holdings, Inc. and for general corporate purposes. Glass Container Holdings, Inc. is the parent company of Anchor Glass Container Corporation, a leading manufacturer of glass packaging for beer, liquor, food, beverage, ready‑to‑drink and consumer end‑markets. The transactions closed on December 7, 2016.
The Cravath team included partners Paul H. Zumbro and Craig F. Arcella, senior attorney Sarah F. Rosen and associates Isaac C. Beerman, Bethany A. Pfalzgraf, Samuel P. Niles, Noah X. DeBlasi and Shakera M. Thompson on banking matters; practice area attorney Janet L. Lewis on real estate matters; partner Matthew Morreale on environmental matters; and partner Eric W. Hilfers on executive compensation and benefits matters. Anthony J. Ramirez and Nathan H. Trunnell also worked on banking matters and Christopher C. Gonnella also worked on executive compensation and benefits matters.
Deals & Cases
February 20, 2026
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 24, 2025
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
Deals & Cases
November 24, 2025
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $2 billion revolving credit facility made available to Thomson Reuters Corporation, a leading AI and technology company empowering professionals with trusted content and workflow automation. The transaction closed on November 10, 2025.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.